← Back to Clinical Trials
Recruiting NCT05886725

NCT05886725 At-home Walking Cadence Functional Assessment and Recovery Trajectory for Older Adults Undergoing Major Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05886725
Status Recruiting
Phase
Sponsor University of Chicago
Condition Gait, Unsteady
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2023-01-02
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 60 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Patients using Step Test Application and Accelerometer

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2023-01-02 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This is a prospective observational study looking at gait-cadence in older adults who are scheduled to have major abdominal surgery at the University of Chicago. The objective of the study is to evaluate whether gait-cadence, as measured from a patient's mobile device at-home, can provide an accurate assessment of a patient's functional status prior to major abdominal surgery and identify patients at risk of poor functional outcomes.

Eligibility Criteria

Inclusion Criteria: * Patients \> or = 60 years of age and scheduled for surgery. * Access to a safe walking space roughly 30 ft in length. Safe walking spaces include a long hallway in the home, common use hallway in an apartment building or outside public area. * Able to walk independently with or without an assistive device (e.g. cane or walker) Exclusion Criteria: * Inability to walk independently * Surgery scheduled less than 7-days after APMC appointment * Patients scheduled for orthopedic surgery * Patients scheduled for neurological surgery * Patients scheduled for cardiac surgery * Non-English speaking.

Contact & Investigator

Central Contact

Daniel Rubin, MD

✉ drubin2@bsd.uchicago.edu

📞 773-702-6856

Principal Investigator

Daniel Rubin

PRINCIPAL INVESTIGATOR

University of Chicago

Frequently Asked Questions

Who can join the NCT05886725 clinical trial?

This trial is open to participants of all sexes, aged 60 Years or older, studying Gait, Unsteady. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05886725 currently recruiting?

Yes, NCT05886725 is actively recruiting participants. Contact the research team at drubin2@bsd.uchicago.edu for enrollment information.

Where is the NCT05886725 trial being conducted?

This trial is being conducted at Chicago, United States.

Who is sponsoring the NCT05886725 clinical trial?

NCT05886725 is sponsored by University of Chicago. The principal investigator is Daniel Rubin at University of Chicago. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology